JOINT ONE
JOINT ONE, licence 80107189: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- ORPIN INC.
- NPN or DIN-HM
- 80107189
- Status
- Active licence
- Licence date
- 11 January 2021
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Gallus gallus Source : Shell | 500.0 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Dioxyde de silicium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 1.0 par jour |
Uses authorised in Canada
Éprouvé en clinique afin de réduire la douleur articulaire en 7-10 jours. Aide à réduire chez les femmes pré-ménopausées les niveaux de CTX-II, un bio-marqueur de la dégradation du cartilage due à de l'exercice aérobique d'intensité modérée. Aide à soulager la douleur articulaire et la raideur articulaire associée à l'ostéoarthrite.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé avant usage si vous êtes enceintes ou allaitez. Si les symptômes persistent ou s'aggravent, consulter un praticien de soins de santé.
- Contre-indications
Ne pas utiliser ce produit si vous êtes allergique aux oeufs.
Source
Official Health Canada record, licence 80107189
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.